8.JPG)
The Protein Design and Engineering Market Size is valued at USD 5.47 Bn in 2023 and is predicted to reach USD 14.69 Bn by the year 2031 at a 13.39% CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
- The increasing cases of chronic & infectious diseases such as diabetes, cardiovascular conditions, and cancer is driving the protein design and engineering market.
- Fast advancements in technologies such as recombinant DNA technology, computational simulation methods, and experimental/molecular methods are driving the protein design and engineering market.
- North America dominated the market and accounted for a global revenue share in 2023.
- The expensive instruments and increasing maintenance costs of protein engineering equipment are a challenge for the market.
The Protein engineering and designing techniques are used to identify specific amino acid sequence changes and alter this sequence for desired functional properties. Mainly computational simulation methods and experimental/molecular methods are utilized for protein engineering.
Major factors such as increasing government initiatives & funding for the development of protein designing systems, fast advancements in technologies are primarily driving the market growth. High prevalence of protein-deficient diseases, and the surging demand for protein engineering tools by biopharmaceutical companies is also expected to support the market growth. The increasing collaborations between companies operating in this market to develop new testing technologies and accelerate the resource-intensive process of protein engineering are enhancing the growth opportunities of the protein design and engineering market. For instance, in January 2021, Zymvol Biomodeling (Spain) collaborated with Aminoverse, a biotech company specializing in enzyme discovery and design, to develop custom-made alcohol dehydrogenases, an enzyme most commonly used in the flavors and fragrances and the fine chemicals industry.
However, the expensive instruments and the increasing maintenance cost of the protein engineering equipment may hinder the market growth during the estimated timeframe.
Market Segmentation
The Protein design and engineering market is segmented into the protein engineering approach used, protein types, type of application, end-users, and region. The protein engineering approach used segment comprises rational designing, directed evolution, and semi-rational designing. The rational designing segment is estimated to dominate this market during the forecast period due to its rising use in antibody and enzyme designing. The market is classified into antibodies, peptides, enzymes, vaccines, and others based on the protein types. The antibodies are expected to be the fastest-growing segment of this market, owing to their increasing applications in the medical sector. The market is grouped into therapeutics and diagnostics by type of application. The market is segmented into pharma/biotech firms, CROs (contract research organizations) & research, and academic institutes by end-users. The pharma/biotech firms are projected to hold a significant market share in the coming years due to the rising demand for advanced drug and therapy treatments to cure chronic diseases. Region-wise, the market is studied across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The Asia-Pacific market is likely to witness rapid growth during the forecast period (2019-2030) due to the well-established healthcare infrastructure, growing awareness regarding protein engineering, and the rising government efforts to develop protein designing methods.
Recent Developments:
- In April 2023, Swiss Adaptyv Biosystems Sàrl has launched two fast-feedback tools for cheap, rapid validation of AI-designed proteins, revolutionizing life sciences with machine learning and generative AI for accelerated drug discovery and material development.
Protein Design and Engineering Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 5.47 Bn |
|
Revenue Forecast In 2031 |
USD 14.69 Bn |
|
Growth Rate CAGR |
CAGR of 13.39% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn, and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Protein Engineering Approach Used, Protein Types, Type Of Application, End-users |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
ATUM (US), Creative BioMart (US), Creative Biostructure (US), Creative Enzymes (US), Absolute Antibody (UK), EUCODIS Bioscience (Austria), Fusion Antibodies (UK), Innovagen (Sweden), ZYMVOL (Spain), Averring Biotech, EnzymeWorks (China), GeNext Genomics (India), Quantumzyme (India), and others. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your specific requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
